Latest Press Releases
View all
TimeHeadline
13m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
45m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
45m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
45m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
45m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Endra Life Sciences Inc logo

Endra Life Sciences Inc

About

Endra Life Sciences Inc (NASDAQ:NDRA) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 25 2026
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
Feb 26 2026
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
Dec 4 2025
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
Nov 20 2025
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

Financials

Revenue
$0
Market Cap
$6.59 M
EPS
-8.93

Community Chat

Ask AI

6ix6ixAIEvents